Drug profile · INN
abarelix
PLENAXIS
abarelix (PLENAXIS) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
Drug details — abarelix
- US status
- approved
- Class
- —
- Route
- INTRAMUSCULAR
- Patents
- 0
- Programs
- 1
- Data quality
- 0.84
Quick answer
abarelix (PLENAXIS) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
Key facts
Mechanism of action
Gonadotropin-releasing hormone receptor antagonist
Primary target: Gonadotropin-releasing hormone receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Pipeline programs
Related & competitor drugs
Frequently asked questions
What is abarelix?
abarelix (PLENAXIS) is a gonadotropin-releasing hormone receptor antagonist. Route of administration: intramuscular. Current US regulatory status: approved.
What is the brand name for abarelix?
PLENAXIS is a marketed brand name for abarelix. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of abarelix?
abarelix has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.